| Literature DB >> 32079345 |
Hélio J Coelho-Júnior1,2,3, Riccardo Calvani1,4, Anna Picca1,4, Ivan O Gonçalves5, Francesco Landi1,4, Roberto Bernabei1,4, Matteo Cesari6,7, Marco C Uchida2, Emanuele Marzetti1,4.
Abstract
The present study investigated the associations between frailty status and (a) daily protein intake, (b) daily body weight-adjusted protein intake, (c) branched-chain amino acid (BCAA) consumption, (d) evenness of protein distribution across main meals, (e) number of daily meals providing at least 30 g of protein, and (f) number of daily meals providing at least 0.4 g protein/kg of body weight in community-dwelling older adults. The relationship between frailty status and protein-related dietary parameters was explored across different frailty assessment tools. Two hundred older adults were enrolled in the study. Participant frailty status was determined according to a modified Fried's frailty phenotype (mFP), the FRAIL scale, and the Study of Osteoporotic Fracture (SOF) index. Diet was assessed by 24-h dietary recall, while diet composition was estimated using a nutritional software. A frailty instrument-dependent relationship was observed between frailty status and protein-related dietary parameters. Protein consumption was associated with frailty status only in participants identified as frail according to the mFP. In addition, protein and BCAA intake was found to be greater in robust and pre-frail participants relative to their frail counterparts. Our findings suggest that the association between frailty and protein-related dietary parameters is tool dependent. Specifically, protein and BCAA consumption appears to be lower only in older adults identified as frail by the mFP.Entities:
Keywords: aging; amino acids; diet; dietary patterns; disability; metabolism; nutrition; physical function; protein per meal; sarcopenia
Mesh:
Substances:
Year: 2020 PMID: 32079345 PMCID: PMC7071300 DOI: 10.3390/nu12020508
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Characteristics of study participants according to frailty status across frailty assessment instruments.
| FRAIL | mFP | SOF | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variables | Robust ( | Pre-Frail ( | Frail ( | Robust ( | Pre-Frail ( | Frail ( | Robust ( | Pre-Frail ( | Frail ( |
|
| |||||||||
| Age, years | 66.0 ± 4.5 | 68.8 ± 7.3 | 67.6 ± 6.4 | 65.1 ± 7.5 | 67.8 ± 6.1 | 71.2 ± 9.1 | 68.6 ± 8.0 | 68.2 ± 6.9 | 68.0 ± 6.1 |
| Body weight, kg | 66.5 ± 11.7 | 69.6 ± 12.7 | 68.2 ± 10.4 | 63.5 ± 9.2 | 69.9 ± 12.1 a | 66.4 ± 12.4 | 68.8 ± 12.2 | 69.7 ± 12.0 | 66.7 ± 12.0 |
| BMI, kg/m2 | 28.1 ± 4.4 | 28.9 ± 5.3 | 28.5 ± 4.3 | 27.7 ± 3.6 | 28.9 ± 5.0 | 28.4 ± 5.5 | 29.4 ± 5.2 | 29.0 ± 4.8 | 27.5 ± 5.1 |
| Physical activity levels, min/week | 490.7 ± 112.3 | 487.5 ± 92.4 | 473.4 ± 100.0 | 476.4 ± 81.9 | 497.1 ± 88 | 430.0 ± 123.2 b | 490.7 ± 112.3 | 487.5 ± 92.4 | 473.4 ± 100.6 |
| Sex, female | 18 (81.8) | 103 (81.7) | 45 (86.5) | 13 (92.9) | 125 (81.2) | 27 (87.1) | 22 (81.5) | 106 (83.5) | 38 (82.6) |
| Current smokers | 0 (0.0) | 3 (2.4) | 3 (5.8) | 1 (7.1) | 4 (2.6) | 1 (3.2) | 0 (0.0) | 3 (2.4) | 3 (6.5) |
| Multimorbidity | 0 (0.0) | 7 (5.6) | 7 (13.5) | 2 (14.3) | 6 (3.9) | 6 (19.4) | 4 (14.8) | 9 (7.1) | 1 (2.2) |
|
| |||||||||
| Asian | 0 (0.0) | 8 (6.3) | 3 (5.8) | 0 (0.0) | 9 (5.8) | 2 (6.5) | 0 (0.0) | 7 (5.5) | 4 (8.7) |
| Black | 3 (13.6) | 22 (17.5) | 12 (23.1) | 2 (14.3) | 28 (18.2) | 7 (22.6) | 6 (22.2) | 22 (17.3) | 9 (19.6) |
| Caucasian | 19 (86.4) | 96 (76.2) | 37 (71.2) | 12 (85.7) | 117 (76.0) | 22 (71.0) | 21 (77.8) | 98 (77.2) | 33 (71.7) |
|
| |||||||||
| Protein, g | 112.6 ± 47.3 | 105.4 ± 40.8 | 104.9 ± 38.7 | 122.2 ± 37.3 | 108.2 ± 41.4 | 89.7 ± 36.4 a,b | 106.4 ± 43.8 | 107.4 ± 41.4 | 102.4 ± 38.3 |
| Protein, g/kg | 1.7 ± 0.8 | 1.5 ± 0.6 | 1.5 ± 0.5 | 1.9 ± 0.6 | 1.5 ± 0.6 | 1.3 ± 0.4 a | 1.6 ± 0.7 | 1.5 ± 0.6 | 1.5 ± 0.5 |
| Valine, g | 5.5 ± 2.3 | 5.2 ± 2.1 | 5.3 ± 2.1 | 6.1 ± 1.9 | 5.4 ± 2.1 | 4.4 ± 1.9ab | 5.2 ± 2.1 | 5.3 ± 2.1 | 5.0 ± 2.0 |
| Isoleucine, g | 4.6 ± 2.9 | 4.7 ± 2.3 | 4.7 ± 2.0 | 5.3 ± 2.2 | 4.8 ± 2.3 | 3.9 ± 1.9ab | 4.4 ± 2.7 | 4.8 ± 2.3 | 4.6 ± 1.9 |
| Leucine, g | 8.4 ± 3.5 | 7.9 ± 3.2 | 7.9 ± 3.0 | 9.3 ± 2.9 | 8.2 ± 3.2 | 6.7 ± 2.9ab | 7.9 ± 3.2 | 8.1 ± 3.2 | 7.7 ± 3.0 |
| Protein breakfast, g | 11.4 ± 5.2 | 13.3 ± 7.1 | 12.9 ± 7.4 | 12.8 ± 5.2 | 12.9 ± 7.7 | 12.6 ± 7.1 | 11.7 ± 4.7 | 13.1 ± 7.1 | 12.8 ± 9.4 |
| Protein lunch, g | 59.5 ± 33.6 | 54.8 ± 26.4 | 58.5 ± 28.4 | 70.2 ± 28.4 | 56.2 ± 28.5 | 50.8 ± 22.0 | 56.4 ± 30.8 | 56.3 ± 28.1 | 56.3 ± 27.7 |
| Protein dinner, g | 31.0 ± 29.7 | 23.9 ± 27.2 | 21.7 ± 25.7 | 28.3 ± 30.9 | 25.8 ± 27.7 | 14.9 ± 21.0 | 25.4 ± 29.3 | 24.8 ± 27.6 | 21.6 ± 24.8 |
| Protein breakfast, g/kg | 0.17 ± 0.09 | 0.19 ± 0.10 | 0.17 ± 0.12 | 0.20 ± 0.09 | 0.18 ± 0.11 | 0.18 ± 0.10 | 0.17 ± 0.81 | 0.19 ± 0.11 | 0.18 ± 0.11 |
| Protein lunch, g/kg | 0.90 ± 0.55 | 0.81 ± 0.41 | 0.86 ± 0.41 | 1.1 ± 0.46 | 0.82 ± 0.44 | 0.76 ± 0.30 | 0.82 ± 0.50 | 0.83 ± 0.43 | 0.85 ± 0.3. |
| Protein dinner, g/kg | 0.49 ± 0.49 | 0.35 ± 0.40 | 0.30 ± 0.37 | 0.46 ± 0.51 | 0.38 ± 0.41 | 0.20 ± 0.29 | 0.40 ± 0.48 | 0.36 ± 0.41 | 0.30 ± 0.37 |
Data are presented as means ± standard deviations, except for sex, current smokers, multimorbidity (i.e., ≥5 diseases), and ethnicity, which are shown as absolute numbers and percentages. Abbreviations: BMI, body mass index; mFP, modified frailty phenotype; SOF, Study of Osteoporotic Fractures. a p < 0.05 vs. robust; b p < 0.05 vs. pre-frail.
Figure 1Venn diagram showing the extent of overlap of frailty categories among the three frailty screening tools used. Abbreviations: mFP, modified frailty phenotype; SOF, Study of Osteoporotic Fractures.
Frequency (%) of distribution of older adults according to diet characteristics and frailty status.
| FRAIL | mFP | SOF | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variables | Robust ( | Pre-Frail ( | Frail ( | Robust ( | Pre-Frail ( | Frail ( | Robust ( | Pre-Frail ( | Frail ( |
|
| |||||||||
| <0.8 | 0 (0.0) | 8 (4.0) | 3 (1.5) | 0 (0.0) | 10 (5.0) | 1 (5.0) | 0 (0.0) | 7 (3.5) | 4 (2.0) |
| ≥0.8 | 22 (11.0) | 118 (59.0) | 49 (24.5) | 14 (7.0) | 144 (72.4) | 30 (15.1) | 27 (13.5) | 120 (60.0) | 42 (21.0) |
|
| |||||||||
| <1.0 | 2 (1.0) | 27 (13.5) | 10 (5.0) | 0 (0.0) | 30 (15.1) | 9 (4.5) | 4 (2.0) | 26 (13.0) | 9 (4.5) |
| ≥1.0 | 20 (10.0) | 99 (49.5) | 42 (21.0) | 14 (7.0) | 124 (62.3) | 22 (11.1) | 23 (11.5) | 101 (50.5) | 37 (18.5) |
|
| |||||||||
| <1.2 | 10 (5.0) | 39 (19.5) | 16 (8.0) | 2 (1.0) | 50 (25.1) | 12 (6.0) | 12 (6.0) | 38 (19.0) | 15 (7.5) |
| ≥1.2 | 12 (6.0) | 87 (43.5) | 36 (18.0) | 12 (6.0) | 104 (52.3) | 19 (9.5) | 15 (7.5) | 89 (44.5) | 31 (15.5) |
|
| |||||||||
| <1.5 | 12 (6.0) | 66 (33.0) | 25 (12.5) | 4 (2.0) | 78 (39.2) | 20 (10.1) | 17 (8.5) | 65 (32.5) | 21 (10.5) |
| ≥1.5 | 10 (5.0) | 60 (30.0) | 27 (13.5) | 10 (5.0) | 76 (38.2) | 11 (5.5) | 10 (5.0) | 62 (31.0) | 25 (12.5) |
|
| |||||||||
| <4.4 | 12 (6.0) | 62 (31.0) | 25 (12.5) | 5 (2.5) | 67 (33.7) | 26 (13.1) | 17 (8.5) | 56 (28.0) | 26 (13.0) |
| ≥4.4 | 10 (5.0) | 64 (32.0) | 27 (13.5) | 9 (4.5) | 87 (43.7)* | 5 (2.5)* | 10 (5.0) | 71 (35.5) | 20 (10.0) |
|
| |||||||||
| <7.1 | 11 (5.5) | 62 (31.0) | 26 (13.0) | 5 (2.5) | 67 (33.7) | 26 (13.1) | 16 (8.0) | 56 (28.0) | 27 (13.5) |
| ≥7.1 | 11 (5.5) | 64 (32.0) | 26 (13.0) | 9 (4.5) | 87 (43.7)* | 5 (2.5)* | 11 (5.5) | 71 (35.5) | 19 (9.5) |
|
| |||||||||
| <4.7 | 12 (6.0) | 62 (31.0) | 26 (13.0) | 5 (2.5) | 68 (34.2) | 26 (13.1) | 17 (8.5) | 57 (28.5) | 26 (13.0) |
| ≥4.7 | 10 (5.0) | 64 (32.0) | 26 (13.0) | 9 (4.5) | 86 (43.2) * | 5 (2.5) * | 10 (5.0) | 70 (35.0) | 20 (10.0) |
|
| |||||||||
| <0.38 | 6 (3.0) | 52 (26.0) | 18 (9.0) | 6 (3.0) | 57 (28.6) | 13 (6.5) | 6 (3.0) | 53 (26.5) | 17 (8.5) |
| 0.38–0.45 | 16 (8.0) | 71 (35.5) | 32 (16.0) | 8 (4.0) | 94 (47.2) | 16 (8.0) | 21 (10.5) | 71 (35.5) | 27 (13.5) |
| >0.45 | 0 (0.0) | 3 (1.5) | 2 (1.0) | 0 (0.0) | 3 (1.5) | 2 (1.0) | 0 (0.0) | 3 (1.5) | 2 (1.0) |
|
| |||||||||
| 0 | 1 (5.0) | 15 (7.5) | 8 (4.0) | 1 (5.0) | 19 (9.5) | 4 (2.0) | 1 (5.0) | 16 (8.0) | 7 (3.5) |
| 1 | 14 (7.0) | 74 (37.0) | 28 (14.0) | 9 (4.5) | 84 (42.2) | 22 (11.1) | 19 (9.5) | 72 (36.0 | 25 (12.5) |
| ≥2 | 7 (3.5) | 37 (18.5) | 16 (8.0) | 4 (2.0) | 51 (25.6) | 5 (2.5) | 7 (3.5) | 39 (19.5) | 14 (7.0) |
|
| |||||||||
| 0 | 1 (5.0) | 15 (7.5) | 8 (4.0) | 1 (5.0) | 19 (9.5) | 4 (2.0) | 1 (5.0) | 16 (8.0) | 7 (3.5) |
| 1 | 14 (7.0) | 74 (37.0) | 28 (14.0) | 9 (4.5) | 84 (42.2) | 22 (11.1) | 19 (9.5) | 72 (36.0 | 25 (12.5) |
| ≥2 | 7 (3.5) | 37 (18.5) | 16 (8.0) | 4 (2.0) | 51 (25.6) | 5 (2.5) | 7 (3.5) | 39 (19.5) | 14 (7.0) |
Abbreviations: CV, coefficient of variation; mFP, modified frailty phenotype; SOF, Study of Osteoporotic Fractures; * Z-score ≥ 1.96 vs. participants with low intake in the same frailty category.